PARIS/MILAN — France has canceled its order for Merck & Co’s COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer’s competing drug before the end of January, the health minister said on Wednesday. Read More
Advertisements
Daily Digest Signup
Daily business and market business news, business management tips, market research insights, and more.
Advertisements
